600079 人福医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,647,9552,164,2651,967,2502,441,0712,178,811
投资活动产生之现金流量净额(373,003)(742,025)(1,224,718)1,226,790(1,420,209)
筹资活动产生之现金流量净额(1,454,245)(1,497,997)(2,105,567)(4,244,942)(913,998)
汇率变动对现金及现金等价物的影响9,556(23,867)16,29948,452(24,956)
现金及现金等价物净增加/(减少)(169,737)(99,624)(1,346,737)(528,629)(180,353)
期初现金及现金等价物余额2,890,8202,990,4454,337,1814,865,8115,046,163
期末现金及现金等价物余额2,721,0832,890,8202,990,4454,337,1814,865,811